These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16157445)

  • 1. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma.
    Bøhn SK; Smeland S; Sakhi AK; Thoresen M; Russnes KM; Tausjø J; Svilaas A; Svilaas T; Blomhoff R
    Cancer Lett; 2006 Jul; 238(2):240-7. PubMed ID: 16157445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma.
    Sakhi AK; Bøhn SK; Smeland S; Thoresen M; Smedshaug GB; Tausjø J; Svilaas A; Karlsen A; Russnes KM; Svilaas T; Blomhoff R
    Nutr Cancer; 2010; 62(3):322-8. PubMed ID: 20358469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
    Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
    Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
    Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.
    Eriksen JG; Alsner J; Steiniche T; Overgaard J
    Radiother Oncol; 2005 Aug; 76(2):135-42. PubMed ID: 16024113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the head and neck: the university of Miami experience.
    Hatoum GF; Patton B; Takita C; Abdel-Wahab M; LaFave K; Weed D; Reis IM
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):477-81. PubMed ID: 19004574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
    Kao J; Lavaf A; Teng MS; Huang D; Genden EM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study.
    Sakhi AK; Russnes KM; Thoresen M; Bastani NE; Karlsen A; Smeland S; Blomhoff R
    BMC Cancer; 2009 Dec; 9():458. PubMed ID: 20025747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
    Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Christiansen H; Hermann RM; Martin A; Florez R; Kahler E; Nitsche M; Hille A; Steiner W; Hess CF; Pradier O
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1067-74. PubMed ID: 16750331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival.
    Italiano A; Ortholan C; Dassonville O; Poissonnet G; Thariat J; Benezery K; Vallicioni J; Peyrade F; Marcy PY; Bensadoun RJ
    Cancer; 2008 Dec; 113(11):3160-8. PubMed ID: 18932260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy with fast neutrons as palliative treatment of advanced recurrences of previously irradiated head and neck tumors].
    Micke O; Prott FJ; Schäfer U; Willich N
    Rontgenpraxis; 2000; 52(9):287-94. PubMed ID: 10936958
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.